System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Publications

Journal Article Epublish 5 citations

PubMed: 35789833 DOI: 10.1016/j.isci.2022.104562

Computational design and engineering of an strain producing the nonstandard amino acid -aminophenylalanine.

iScience 25(7):104562

Authors: Ali R Zomorrodi, Colin Hemez, Pol Arranz-Gibert, Terrence Wu, Farren J Isaacs, Daniel Segrè

Affiliations

  • Mucosal Immunology and Biology Research Center, Pediatrics Department, Massachusetts General Hospital, Boston, MA, USA.
  • Harvard Medical School, Boston, MA, USA.
  • Bioinformatics Graduate Program, Boston University, Boston, MA, USA.
  • Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT, USA.
  • Systems Biology Institute, Yale University, West Haven, CT, USA.
  • Department of Biomedical Engineering, Yale University, New Haven, CT, USA.
  • Yale West Campus Analytical Core, 600 West Campus Drive, West Haven, USA.
  • Department of Biology, Boston University, Boston, MA, USA.
  • Department of Biomedical Engineering, Boston University, Boston, MA, USA.
  • Biological Design Center, Boston University, Boston, MA, USA.

Abstract

Introducing heterologous pathways into host cells constitutes a promising strategy for synthesizing nonstandard amino acids (nsAAs) to enable the production of proteins with expanded chemistries. However, this strategy has proven challenging, as the expression of heterologous pathways can disrupt cellular homeostasis of the host cell. Here, we sought to optimize the heterologous production of the nsAA -aminophenylalanine (pAF) in . First, we incorporated a heterologous pAF biosynthesis pathway into a genome-scale model of metabolism and computationally identified metabolic interventions in the host's native metabolism to improve pAF production. Next, we explored different approaches of imposing these flux interventions experimentally and found that the upregulation of flux in the chorismate biosynthesis pathway through the elimination of feedback inhibition mechanisms could significantly raise pAF titers (∼20-fold) while maintaining a reasonable pAF production-growth rate trade-off. Overall, this study provides a promising strategy for the biosynthesis of nsAAs in engineered cells.

MeSH

Cells, Amino Acids